HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid leukemia (IMAGE)

St. Jude Children's Research Hospital

HOXA9 tracking reveals RBM5 dual function and therapeutic potential for acute myeloid leukemia

Caption

Chunliang Li, PhD, St. Jude Department of Tumor Cell Biology, along with his team and collaborators, identified RBM5 as key player in HOXA9-linked AML development, also revealing an unexpected dual function of the protein

Credit

St. Jude Children's Research Hospital

Usage Restrictions

No cropping

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.